Thomas Heinrich Glanzmann

Thomas Heinrich Glanzmann is the founder of Medical Technology Ventures LLC, holding the title of Partner since 2016.
Mr. Glanzmann is the founder of Medical Technology Venture Partners, holding the title of Partner since 2017.
Current jobs include Chairman at Grifols, Inc. since 2011, Independent Director at Alcon AG since 2019, Director at Sage Products LLC, Director at Alcon NV, and Director at Alcon Vision LLC.
Former jobs include President & Chief Executive Officer at Gambro AB from 2006 to 2011, Chief Executive Officer at HemoCue AB from 2005 to 2012, Chief Executive Officer at Immuno International AG from 1996 to 1998, Chief Executive Officer & President at Gambro Lundia AB from 2006 to 2011, Chairman at Plasma Protein Therapeutics Association from 2000 to 2001, Executive Chairman at Grifols SA in 2024, Chairman at Grifols Shared Services North America, Inc., Independent Non-Executive Director at Sulzer AG from 2012 to 2018, Director at Alkahest, Inc., Managing Director-Davos Region at Forum Mondial de L'Economie from 2004 to 2005, Senior Vice President at Baxter Healthcare Corp.
from 1998 to 2004, Country Manager at Philip Morris Spain SA from 1984 to 1988, President at Baxter BioScience Corp.
from 1988 to 2004, Senior Vice President at Baxter AG, and Senior Vice President at Baxter World Trade Corp.
Education includes an undergraduate degree from Dartmouth College and an MBA from the International Institute for Management Development.